Targeting tight junction proteins-significance for drug development

Drug Discovery Today

Volumn 13, Issue 3-4, 2008, Pages 180-186

  Kondoh, Masuo ^a   Yoshida, Takeshi ^a   Kakutani, Hideki ^a   Yagi, Kiyohito ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN; DECANOIC ACID; EDETIC ACID; FOLLITROPIN; G PROTEIN COUPLED RECEPTOR; MEMBRANE PROTEIN; NITRIC OXIDE; OCCLUDIN; OLEIC ACID; PEPTIDE;

CELL MEMBRANE; CELL MOTILITY; CELL POLARITY; CELL SURVIVAL; CYTOLOGY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG TARGETING; ELECTRON MICROSCOPY; GENE CONTROL; GENE EXPRESSION; GENE THERAPY; HUMAN; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; TIGHT JUNCTION; UPREGULATION;

ANIMALS; CELL MEMBRANE PERMEABILITY; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; PEPTIDE FRAGMENTS; TIGHT JUNCTIONS;

EID: 39149117688     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2007.11.005     Document Type: Review

References (74)

1. Hopkins A.L., and Groom C.R. The druggable genome. Nat. Rev. Drug Discov. 1 (2002) 727-730
2. Overington J.P., et al. How many drug targets are there?. Nat. Rev. Drug Discov. 5 (2006) 993-996
3. Mizuno N., et al. Impact of drug transporter studies on drug discovery and development. Pharmacol. Rev. 55 (2003) 425-461
4. Allen T.M., and Cullis P.R. Drug delivery systems: entering the mainstream. Science 303 (2004) 1818-1822
5. Farquhar M.G., and Palade G.E. Junctional complexes in various epithelia. J. Cell Biol. 17 (1963) 375-412
6. Scheneeberger E.E., and Lynch R.D. Structure, function, and regulation of cellular tight junctions. Am. J. Physiol. 262 (1992) L647-L661
7. Furuse M., and Tsukita S. Claudins in occluding junctions of humans and flies. Trends Cell Biol. 16 (2006) 181-188
8. Rodriguez-Boulan E., and Nelson W.J. Morphogenesis of the polarized epithelial cell phenotype. Science 245 (1989) 718-725
9. Vermeer P.D., et al. Segregation of receptor and ligand regulates activation of epithelial growth factor receptor. Nature 422 (2003) 322-326
10. Furuse M., et al. Occludin: a novel integral membrane protein localizing at tight junctions. J. Cell Biol. 123 Pt 2 (1993) 1777-1788
11. Hirase T., et al. Occludin as a possible determinant of tight junction permeability in endothelial cells. J. Cell Sci. 110 Pt 14 (1997) 1603-1613
12. Moroi S., et al. Occludin is concentrated at tight junctions of mouse/rat but not human/guinea pig Sertoli cells in testes. Am. J. Physiol. 274 Pt 1 (1998) C1708-C1717
13. Saitou M., et al. Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. J. Cell Biol. 141 (1998) 397-408
14. Furuse M., et al. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J. Cell Biol. 141 (1998) 1539-1550
15. Morita K., et al. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc. Natl Acad. Sci. U. S. A. 96 (1999) 511-516
16. Furuse M., et al. A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J. Cell Biol. 143 (1998) 391-401
17. Tsukita S., and Furuse M. Occludin and claudins in tight-junction strands: leading or supporting players?. Trends Cell Biol. 9 (1999) 268-273
18. Furuse M., et al. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J. Cell Biol. 156 (2002) 1099-1111
19. Nitta T., et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 161 (2003) 653-660
20. Gow A., et al. CNS myelin and sertoli cell tight junction strands are absent in Osp/claudin-11 null mice. Cell 99 (1999) 649-659
21. Morita K., et al. Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J. Cell Biol. 147 (1999) 185-194
22. Furuse M., et al. Manner of interaction of heterogeneous claudin species within and between tight junction strands. J. Cell Biol. 147 (1999) 891-903
23. Furuse M., et al. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J. Cell Biol. 153 (2001) 263-272
24. Tsukita S., and Furuse M. Pores in the wall: claudins constitute tight junction strands containing aqueous pores. J. Cell Biol. 149 (2000) 13-16
25. Van Itallie C.M., et al. Reversal of charge selectivity in cation or anion-selective epithelial lines by expression of different claudins. Am. J. Physiol. Renal Physiol. 285 (2003) F1078-F1084
26. Anderson J. Molecular structure of tight junctions and their role in epithelial transport. News Physiol. Sci. 16 (2001) 126-130 Nephrol. 12, 1872-1881
27. Engel R.H., and Riggi S.J. Effect of sulfated and sulfonated surfactants on the intestinal absorption of heparin. Proc. Soc. Exp. Biol. Med. 130 (1969) 879-884
28. Aungst B.J. Intestinal permeation enhancers. J. Pharm. Sci. 89 (2000) 429-442
29. Citi S. Protein kinase inhibitors prevent junction dissociation induced by low extracellular calcium in MDCK epithelial cells. J. Cell Biol. 117 (1992) 169-178
30. Tomita M., et al. Absorption-enhancing mechanism of EDTA, caprate, and decanoylcarnitine in Caco-2 cells. J. Pharm. Sci. 85 (1996) 608-611
31. Yamamoto A., et al. Modulation of intestinal permeability by nitric oxide donors: implications in intestinal delivery of poorly absorbable drugs. J. Pharmacol. Exp. Ther. 296 (2001) 84-90
32. Wong V., and Gumbiner B. A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J. Cell Biol. 136 (1997) 399-409
33. Lacaz-Vieira F., et al. Small synthetic peptides homologous to segments of the first external loop of occludin impair tight junction resealing. J. Membr. Biol. 168 (1999) 289-297
34. Tavelin S., et al. A new principle for tight junction modulation based on occludin peptides. Mol. Pharmacol. 64 (2003) 1530-1540
35. Evert R.S., et al. Specific modulation of airway epithelial tight junctions by apical application of an occludin peptide. Mol. Pharmacol. 69 (2006) 492-500
36. Wong C.H., et al. Targeted and reversible disruption of the blood-testis barrier by an FSH mutant-occludin peptide conjugate. FASEB J. 21 (2007) 438-448
37. Hanna P.C., et al. Mapping of functional regions of Clostridium perfringens type A enterotoxin. Infect. Immun. 60 (1992) 2110-2114
38. Katahira J., et al. Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin. J. Cell Biol. 136 (1997) 1239-1247
39. Fujita K., et al. Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett. 476 (2000) 258-261
40. Sonoda N., et al. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier. J. Cell Biol. 147 (1999) 195-204
41. Kondoh M., et al. A novel strategy for the enhancement of drug absorption using a claudin modulator. Mol. Pharmacol. 67 (2005) 749-756
42. Tsukita S., et al. Multifunctional strands in tight junctions. Nat. Rev. Mol. Cell Biol. 2 (2001) 285-293
43. Hou J., et al. Study of claudin function by RNA interference. J. Biol. Chem. 281 (2006) 36117-36123
44. Hay E.D. An overview of epithelio-mesenchymal transformation. Acta. Anat. (Basel) 154 (1995) 8-20
45. Ikenouchi J., et al. Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by Snail. J. Cell Sci. 116 Pt 10 (2003) 1959-1967
46. Kramer F., et al. Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer. Hum. Genet. 107 (2000) 249-256
47. Tokes A.M., et al. Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res. 7 (2005) R296-R305
48. Resnick M.B., et al. Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod. Pathol. 18 (2005) 511-518
49. Kominsky S.L., et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 22 (2003) 2021-2033
50. Al Moustafa A.E., et al. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 21 (2002) 2634-2640
51. Michl P., et al. Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res. 63 (2003) 6265-6271
52. Li D., and Mrsny R.J. Oncogenic Raf-1 disrupts epithelial tight junctions via downregulation of occludin. J. Cell Biol. 148 (2000) 791-800
53. Litkouhi B., et al. Claudin-4 overexpression in epithelial ovarian cancer is associated with hypomethylation and is a potential target for modulation of tight junction barrier function using a C-terminal fragment of Clostridium perfringens enterotoxin. Neoplasia. 9 (2007) 304-314
54. Ding S., et al. Methylation profile of the promoter CpG islands of 14 drug-resistance genes in hepatocellular carcinoma. World J. Gastroenterol. 10 (2004) 3433-3440
55. Osanai M., et al. Epigenetic silencing of occludin promotes tumorigenic and metastasis properties of cancer cells via modulations of unique sets of apoptosis-associated genes. Cancer Res. 66 (2006) 9125-9133
56. Morin P.J. Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res. 65 (2005) 9603-9606
57. Morita K., et al. Tight junction-associated proteins (occludin, ZO-1, claudin-1, claudin-4) in squamous cell carcinoma and Bowen's disease. Br. J. Dermatol. 151 (2004) 328-334
58. Agarwal R., et al. Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res. 65 (2005) 7378-7385
59. Miyamori H., et al. Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases. J. Biol. Chem. 276 (2001) 28204-28211
60. Oku N., et al. Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1. Cancer Res. 66 (2006) 5251-5257
61. Kominsky S.L., et al. Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4. Am. J. Pathol. 164 (2004) 1627-1633
62. Michl P., et al. Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology 121 (2001) 678-684
63. Santin A.D., et al. Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin. Cancer Res. 65 (2005) 4334-4342
64. Ebihara C., et al. Preparation of a claudin-targeting molecule using a C-terminal fragment of Clostridium perfringens enterotoxin. J. Pharmacol. Exp. Ther. 316 (2006) 255-260
65. Ebihara C., et al. Role of Tyr306 in the C-terminal fragment of Clostridium perfringens enterotoxin for modulation of tight junction. Biochem. Pharmacol. 73 (2007) 824-830
66. Harada M., et al. Role of tyrosine residues in modulaion of claudin-4 by the C-terminal fragment of Clostridium perfringens enterotoxin. Biochem. Pharmacol. 73 (2007) 206-214
67. Johnson P.H., and Quay S.C. Advances in nasal drug delivery through tight junction technology. Expert Opin. Drug Deliv. 2 (2005) 281-298
68. Chen X., and Macara I.G. RNA interference techniques to study epithelial cell adhesion and polarity. Methods Enzymol. 406 (2006) 362-374
69. Muthuswamy S.K. ErbB2 makes β4 integrin an accomplice in tumorigenesis. Cell 126 (2006) 443-445
70. Matter K., and Balda M.S. Epithelial tight junctions, gene expression and nucleo-junctional interplay. J. Cell Sci. 120 (2007) 1505-1511
71. Matter K., and Balda M.S. Signaling to and from tight junctions. Nat. Rev. Mol. Cell Biol. 4 (2003) 225-236
72. Balda M.S., and Matter K. The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression. EMBO J. 19 (2000) 2024-2033
73. Citri A., and Yarden Y. EGF-ERBB signaling: towards the systems level. Nat. Rev. Mol. Cell Biol. 7 (2006) 505-516
74. Guo W., et al. β4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 126 (2006) 489-502 2006